The global Antiandrogen market was valued at 6887 million in 2024 and is projected to reach US$ 10300 million by 2032, at a CAGR of 6.1% during the forecast period.
The U.S. market is estimated at $ million in 2024, while China is to reach $ million.
Steroidal Antiandrogen segment will reach $ million by 2032, with a % CAGR in next six years.
The global key players of Antiandrogen include Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui, Bayer, Schering-Plough, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Antiandrogen companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Antiandrogen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiandrogen. This report contains market size and forecasts of Antiandrogen in global, including the following market information:
Global Antiandrogen market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Antiandrogen companies in 2024 (%)
Total Market by Segment:
Global Antiandrogen market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Antiandrogen market segment percentages, by Type, 2024 (%)
Steroidal Antiandrogen
Nonsteroidal Antiandrogen
Global Antiandrogen market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Antiandrogen market segment percentages, by Application, 2024 (%)
Prostate Cancer
Benign Prostatic Hyperplasia
Polycystic Ovary Syndrome (POCS)
Others
Global Antiandrogen market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Antiandrogen market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antiandrogen revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Antiandrogen revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Merck
Sanofi
Orion Corporation
Hengrui
Bayer
Schering-Plough
Hinova Pharma
Jiangsu Hengrui Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antiandrogen, market overview.
Chapter 2: Global Antiandrogen market size in revenue.
Chapter 3: Detailed analysis of Antiandrogen company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antiandrogen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antiandrogen Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Antiandrogen Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antiandrogen Overall Market Size
2.1 Global Antiandrogen Market Size: 2024 VS 2032
2.2 Global Antiandrogen Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antiandrogen Players in Global Market
3.2 Top Global Antiandrogen Companies Ranked by Revenue
3.3 Global Antiandrogen Revenue by Companies
3.4 Top 3 and Top 5 Antiandrogen Companies in Global Market, by Revenue in 2024
3.5 Global Companies Antiandrogen Product Type
3.6 Tier 1, Tier 2, and Tier 3 Antiandrogen Players in Global Market
3.6.1 List of Global Tier 1 Antiandrogen Companies
3.6.2 List of Global Tier 2 and Tier 3 Antiandrogen Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Antiandrogen Market Size Markets, 2024 & 2032
4.1.2 Steroidal Antiandrogen
4.1.3 Nonsteroidal Antiandrogen
4.2 Segmentation by Type - Global Antiandrogen Revenue & Forecasts
4.2.1 Segmentation by Type - Global Antiandrogen Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Antiandrogen Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Antiandrogen Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Antiandrogen Market Size, 2024 & 2032
5.1.2 Prostate Cancer
5.1.3 Benign Prostatic Hyperplasia
5.1.4 Polycystic Ovary Syndrome (POCS)
5.1.5 Others
5.2 Segmentation by Application - Global Antiandrogen Revenue & Forecasts
5.2.1 Segmentation by Application - Global Antiandrogen Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Antiandrogen Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Antiandrogen Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Antiandrogen Market Size, 2024 & 2032
6.2 By Region - Global Antiandrogen Revenue & Forecasts
6.2.1 By Region - Global Antiandrogen Revenue, 2020-2025
6.2.2 By Region - Global Antiandrogen Revenue, 2026-2032
6.2.3 By Region - Global Antiandrogen Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Antiandrogen Revenue, 2020-2032
6.3.2 United States Antiandrogen Market Size, 2020-2032
6.3.3 Canada Antiandrogen Market Size, 2020-2032
6.3.4 Mexico Antiandrogen Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Antiandrogen Revenue, 2020-2032
6.4.2 Germany Antiandrogen Market Size, 2020-2032
6.4.3 France Antiandrogen Market Size, 2020-2032
6.4.4 U.K. Antiandrogen Market Size, 2020-2032
6.4.5 Italy Antiandrogen Market Size, 2020-2032
6.4.6 Russia Antiandrogen Market Size, 2020-2032
6.4.7 Nordic Countries Antiandrogen Market Size, 2020-2032
6.4.8 Benelux Antiandrogen Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Antiandrogen Revenue, 2020-2032
6.5.2 China Antiandrogen Market Size, 2020-2032
6.5.3 Japan Antiandrogen Market Size, 2020-2032
6.5.4 South Korea Antiandrogen Market Size, 2020-2032
6.5.5 Southeast Asia Antiandrogen Market Size, 2020-2032
6.5.6 India Antiandrogen Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Antiandrogen Revenue, 2020-2032
6.6.2 Brazil Antiandrogen Market Size, 2020-2032
6.6.3 Argentina Antiandrogen Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antiandrogen Revenue, 2020-2032
6.7.2 Turkey Antiandrogen Market Size, 2020-2032
6.7.3 Israel Antiandrogen Market Size, 2020-2032
6.7.4 Saudi Arabia Antiandrogen Market Size, 2020-2032
6.7.5 UAE Antiandrogen Market Size, 2020-2032
7 Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Antiandrogen Major Product Offerings
7.1.4 Pfizer Antiandrogen Revenue in Global Market (2020-2025)
7.1.5 Pfizer Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Antiandrogen Major Product Offerings
7.2.4 Johnson & Johnson Antiandrogen Revenue in Global Market (2020-2025)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Antiandrogen Major Product Offerings
7.3.4 AstraZeneca Antiandrogen Revenue in Global Market (2020-2025)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Astellas
7.4.1 Astellas Corporate Summary
7.4.2 Astellas Business Overview
7.4.3 Astellas Antiandrogen Major Product Offerings
7.4.4 Astellas Antiandrogen Revenue in Global Market (2020-2025)
7.4.5 Astellas Key News & Latest Developments
7.5 Merck
7.5.1 Merck Corporate Summary
7.5.2 Merck Business Overview
7.5.3 Merck Antiandrogen Major Product Offerings
7.5.4 Merck Antiandrogen Revenue in Global Market (2020-2025)
7.5.5 Merck Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Corporate Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Antiandrogen Major Product Offerings
7.6.4 Sanofi Antiandrogen Revenue in Global Market (2020-2025)
7.6.5 Sanofi Key News & Latest Developments
7.7 Orion Corporation
7.7.1 Orion Corporation Corporate Summary
7.7.2 Orion Corporation Business Overview
7.7.3 Orion Corporation Antiandrogen Major Product Offerings
7.7.4 Orion Corporation Antiandrogen Revenue in Global Market (2020-2025)
7.7.5 Orion Corporation Key News & Latest Developments
7.8 Hengrui
7.8.1 Hengrui Corporate Summary
7.8.2 Hengrui Business Overview
7.8.3 Hengrui Antiandrogen Major Product Offerings
7.8.4 Hengrui Antiandrogen Revenue in Global Market (2020-2025)
7.8.5 Hengrui Key News & Latest Developments
7.9 Bayer
7.9.1 Bayer Corporate Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Antiandrogen Major Product Offerings
7.9.4 Bayer Antiandrogen Revenue in Global Market (2020-2025)
7.9.5 Bayer Key News & Latest Developments
7.10 Schering-Plough
7.10.1 Schering-Plough Corporate Summary
7.10.2 Schering-Plough Business Overview
7.10.3 Schering-Plough Antiandrogen Major Product Offerings
7.10.4 Schering-Plough Antiandrogen Revenue in Global Market (2020-2025)
7.10.5 Schering-Plough Key News & Latest Developments
7.11 Hinova Pharma
7.11.1 Hinova Pharma Corporate Summary
7.11.2 Hinova Pharma Business Overview
7.11.3 Hinova Pharma Antiandrogen Major Product Offerings
7.11.4 Hinova Pharma Antiandrogen Revenue in Global Market (2020-2025)
7.11.5 Hinova Pharma Key News & Latest Developments
7.12 Jiangsu Hengrui Pharmaceuticals
7.12.1 Jiangsu Hengrui Pharmaceuticals Corporate Summary
7.12.2 Jiangsu Hengrui Pharmaceuticals Business Overview
7.12.3 Jiangsu Hengrui Pharmaceuticals Antiandrogen Major Product Offerings
7.12.4 Jiangsu Hengrui Pharmaceuticals Antiandrogen Revenue in Global Market (2020-2025)
7.12.5 Jiangsu Hengrui Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Antiandrogen Market Opportunities & Trends in Global Market
Table 2. Antiandrogen Market Drivers in Global Market
Table 3. Antiandrogen Market Restraints in Global Market
Table 4. Key Players of Antiandrogen in Global Market
Table 5. Top Antiandrogen Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Antiandrogen Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Antiandrogen Revenue Share by Companies, 2020-2025
Table 8. Global Companies Antiandrogen Product Type
Table 9. List of Global Tier 1 Antiandrogen Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiandrogen Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Antiandrogen Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Antiandrogen Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Antiandrogen Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Antiandrogen Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Antiandrogen Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Antiandrogen Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Antiandrogen Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Antiandrogen Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Antiandrogen Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Antiandrogen Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Antiandrogen Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Antiandrogen Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Antiandrogen Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Antiandrogen Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Antiandrogen Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Antiandrogen Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Antiandrogen Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Antiandrogen Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Antiandrogen Revenue, (US$, Mn), 2026-2032
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Antiandrogen Product Offerings
Table 32. Pfizer Antiandrogen Revenue (US$, Mn) & (2020-2025)
Table 33. Pfizer Key News & Latest Developments
Table 34. Johnson & Johnson Corporate Summary
Table 35. Johnson & Johnson Antiandrogen Product Offerings
Table 36. Johnson & Johnson Antiandrogen Revenue (US$, Mn) & (2020-2025)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. AstraZeneca Corporate Summary
Table 39. AstraZeneca Antiandrogen Product Offerings
Table 40. AstraZeneca Antiandrogen Revenue (US$, Mn) & (2020-2025)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. Astellas Corporate Summary
Table 43. Astellas Antiandrogen Product Offerings
Table 44. Astellas Antiandrogen Revenue (US$, Mn) & (2020-2025)
Table 45. Astellas Key News & Latest Developments
Table 46. Merck Corporate Summary
Table 47. Merck Antiandrogen Product Offerings
Table 48. Merck Antiandrogen Revenue (US$, Mn) & (2020-2025)
Table 49. Merck Key News & Latest Developments
Table 50. Sanofi Corporate Summary
Table 51. Sanofi Antiandrogen Product Offerings
Table 52. Sanofi Antiandrogen Revenue (US$, Mn) & (2020-2025)
Table 53. Sanofi Key News & Latest Developments
Table 54. Orion Corporation Corporate Summary
Table 55. Orion Corporation Antiandrogen Product Offerings
Table 56. Orion Corporation Antiandrogen Revenue (US$, Mn) & (2020-2025)
Table 57. Orion Corporation Key News & Latest Developments
Table 58. Hengrui Corporate Summary
Table 59. Hengrui Antiandrogen Product Offerings
Table 60. Hengrui Antiandrogen Revenue (US$, Mn) & (2020-2025)
Table 61. Hengrui Key News & Latest Developments
Table 62. Bayer Corporate Summary
Table 63. Bayer Antiandrogen Product Offerings
Table 64. Bayer Antiandrogen Revenue (US$, Mn) & (2020-2025)
Table 65. Bayer Key News & Latest Developments
Table 66. Schering-Plough Corporate Summary
Table 67. Schering-Plough Antiandrogen Product Offerings
Table 68. Schering-Plough Antiandrogen Revenue (US$, Mn) & (2020-2025)
Table 69. Schering-Plough Key News & Latest Developments
Table 70. Hinova Pharma Corporate Summary
Table 71. Hinova Pharma Antiandrogen Product Offerings
Table 72. Hinova Pharma Antiandrogen Revenue (US$, Mn) & (2020-2025)
Table 73. Hinova Pharma Key News & Latest Developments
Table 74. Jiangsu Hengrui Pharmaceuticals Corporate Summary
Table 75. Jiangsu Hengrui Pharmaceuticals Antiandrogen Product Offerings
Table 76. Jiangsu Hengrui Pharmaceuticals Antiandrogen Revenue (US$, Mn) & (2020-2025)
Table 77. Jiangsu Hengrui Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Antiandrogen Product Picture
Figure 2. Antiandrogen Segment by Type in 2024
Figure 3. Antiandrogen Segment by Application in 2024
Figure 4. Global Antiandrogen Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Antiandrogen Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Antiandrogen Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Antiandrogen Revenue in 2024
Figure 9. Segmentation by Type � Global Antiandrogen Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Antiandrogen Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Antiandrogen Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Antiandrogen Revenue Market Share, 2020-2032
Figure 13. By Region - Global Antiandrogen Revenue Market Share, 2020-2032
Figure 14. By Country - North America Antiandrogen Revenue Market Share, 2020-2032
Figure 15. United States Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Antiandrogen Revenue Market Share, 2020-2032
Figure 19. Germany Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 20. France Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Antiandrogen Revenue Market Share, 2020-2032
Figure 27. China Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 31. India Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Antiandrogen Revenue Market Share, 2020-2032
Figure 33. Brazil Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Antiandrogen Revenue Market Share, 2020-2032
Figure 36. Turkey Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Antiandrogen Revenue, (US$, Mn), 2020-2032
Figure 40. Pfizer Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Johnson & Johnson Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. AstraZeneca Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Astellas Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Merck Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Sanofi Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Orion Corporation Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Hengrui Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Bayer Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Schering-Plough Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Hinova Pharma Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Jiangsu Hengrui Pharmaceuticals Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
